Epic Corp New (EPOR) 0.0274 $EPOR EPIC, a Pink Sheet

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Epic Corp New (EPOR) 0.0274 $EPOR

EPIC, a Pink Sheet Dividend Company, Announced Its 2nd Exchange Offer and 9th Consecutive Quarterly Stock Dividend
Marketwired - Tue May 05, 8:03AM CDT
EPIC Corporation Inc. (OTC PINK: EPOR) and Ronald Tucker, its CEO, announced:

MoneyTV with Donald Baillargeon, 5/1
PR Newswire - Fri May 01, 4:00AM CDT
California drought politics, solar, mobile payments, business development, waste management, robot calling; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs, providing insights into their operations and outlooks for their futures.

Global Patient Portal Market Outlook to 2020
M2 - Wed Apr 15, 4:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c2blv3/global_patient) has announced the addition of the "Global Patient Portal Market Outlook: 2014-2020" report to their offering. Healthcare IT sector has witnessed many revolutionary technologies over the decades which have transformed the healthcare sector in many aspects. Patient Portal is an online application that allows patients to communicate with doctors and to get the personal health information at any time. Patient is provided with an online portal account secured by a password in order to maintain the privacy of patient's critical health information. Patient Portal provides information on medications; laboratories test result, prescriptions, doctor's appointment, billing and many other aspects of patient-doctor interaction. Global patient portal market is segmented by type of portal, mode of delivery, and end-user. The market is further sub segmented in to EHR based portal, individual third party portal, and others, of which EHR based patient portal are used by most of the healthcare providers and has a major share in the overall patient portal market, cited to its installation feasibility and ease of data access. Patient portal incorporation and usage patterns are meticulously analyzed by segmenting the market on the basis of end-users. The key end-users analyzed in the study are hospitals, physicians, healthcare payers, Health Information Exchange (HIE) organizations, pharmacies, and others. The growing use of IT in healthcare sector, rising demand for integrated systems, various government initiatives such as Accountable care organization (ACO) programs and the introduction of Stage 2 Meaningful Use criteria that abide the healthcare providers to provide the online access to patient regarding their health information boost the growth of global patient portal market. However, various security concerns and low awareness in the developing countries inhibits the growth of this market to a certain extent. The global patient portal market is further segmented on the basis of geographies emphasizing on North America, Europe, Asia-Pacific, and Rest of the World (Africa and Middle East). North American region accounted for the largest share in the global patient portal market followed by Europe, and Asia-Pacific. Asia-Pacific region provides significant opportunities for the growth of this market cited to many technological advancements and healthcare reforms in the region backed by growing economies such as China and India and positive approach of government towards the healthcare IT sector. The patient portals market is fragmented with a presence of lot of small and major companies in the market. The key players in the global patient portal market are Allscripts Healthcare Solutions, Inc. (U.S.), athenahealth (U.S), eClinicalWorks (U.S.), Cerner Corporation (U.S.), Epic (U.S.), GE Healthcare (U.K.), Greenway / Vitera Healthcare Solutions (U.S.), McKesson Corporation (U.S.), and NextGen Healthcare Information System LLC (U.S) along with many small players operating at a regional/local markets. Key Topics Covered: 1 Introduction to Global Patient Portal Market 2 Executive Summary 3 Market Insights 4 Global Patient Portal - Market Crackdown ($ Value Analysis), By Types 5 Global Patient Portal - Market Crackdown ($ Value Analysis), By Mode of delivery 6 Global Patient Portal - Market Crackdown ($ Value Analysis), By End Users 7 Patient Portal - Market Crackdown ($ Value Analysis), By Geography 8 Global Patient Portal Market - Competitive Outlook 9 Competitive Profiles - Major Players - Allscripts Healthcare Solutions - Athenahealth - Cerner - CureMd - eClinicalWorks - eMD - Epic Corporation - GE Healthcare - Greenway (Vitera Healthcare Solutions) - Intellichart - McKesson Coporation (Mckesson Specialty Business) - Medfusion (Former Intuit Health) - MEDITECH - NextGen Healthcare For more information visit http://www.researchandmarkets.com/research/c2...al_patient
MCK: 242.75 (+2.82), MDRX: 14.08 (+0.10), INTU: 102.34 (+0.01), CERN: 68.26 (+0.92)

EPIC Announces New Exchange Offer and EPIC Paid Preferred Stock Dividends in Common Stock of 10.41666% for September, 12.50% for December 2014, 24% for March 2015; EPIC to Raise Capital Pursuant to New Reg A Rules
Marketwired - Thu Apr 02, 8:01AM CDT
EPIC Corporation (OTC PINK: EPOR) ("EPIC" and Ronald S. Tucker announced that "EPIC is offering to exchange common stock held in street name for its Series A 5% Convertible Preferred Stock by shareholders of record on July 10, 2015, and to be paid at a conversion rate to be determined on July 30, 2015. An official Notice of Exchange Offer will be made in the Month of May. In addition, the Board of Directors authorized the filing of a limited Qualified Offering Statement under the new Regulation A Rules. The dividend paid on the number of Preferred Shares outstanding for September 2014 was 10.41666%, December 2014 was 12.50%, and March 2015 was 24%."

EPIC Declares Its Eighth Consecutive Quarterly Preferred Stock Dividend
Marketwired - Mon Mar 02, 1:51PM CST
EPIC Corporation Inc. (OTC PINK: EPOR) and Ronald Tucker its CEO announced "EPIC's Board of Directors declares the eighth consecutive quarterly stock dividend on its Series A 5% Convertible Preferred Stock to preferred shareholders of record on March 24, 2014, which will be paid March 31, 2014. The dividend will be paid to preferred shareholders on the basis of 24% of the preferred shares owned. There are to be no fractional shares, any fractional share will be rounded up to one share."

EPIC Begins Selling AcuFAB Products With the Establishment of Its Product and Distribution Company
Marketwired - Wed Feb 11, 8:03AM CST
EPIC Corporation Inc. (OTC PINK: EPOR) and Ronald Tucker its CEO announced "EPIC has established RX Healthcare Systems, Ltd., a majority owned subsidiary, as its sales and distribution company with the initiation of sales in its various AcuFAB® product lines through independent sales organizations."

Is Apple About to Defy Steve Jobs With the “iPad Pro”?
Leo Sun, The Motley Fool - Motley Fool - Tue Jan 27, 6:22PM CST
When asked about multitasking on iOS back in 2010, Steve Jobs famously said, "if you see a stylus, they blew it." Even after his death in 2011, Apple stuck to that statement, launching stylus-free iPhones and iPads...
AMZN: 425.24 (-0.76), IBM: 173.06 (-0.20), MSFT: 48.01 (-0.28), AAPL: 130.19 (+1.42), CERN: 68.26 (+0.92), ATHN: 120.85 (+0.76)

Epic Offers Common Shareholders Three Methods to Receive a Return on Investment, One Method Could Provide a 500% to 888% Annualized Rate of Return
Marketwired - Mon Jan 12, 8:16AM CST
EPIC Corporation Inc. (OTC PINK: EPOR) and Ronald Tucker it CEO announced "EPIC's Board of Directors has authorized a series of quarterly exchange offerings for its common shareholders in street name to exchange common shares for preferred shares. The first exchange offering is to shareholders of record on March 20, 2014. This offer will to exchange 1 share of EPIC's Series A 5% Convertible Preferred Stock for 1.5 shares of EPIC's common stock. Through the exchange common shareholders will have three methods to receive a return of investment."

EPIC Offers a Second Exchange of Its Series A Preferred Stock in Place of Its Announced Dividend Policy
Marketwired - Mon Dec 22, 5:00AM CST
EPIC Corporation Inc. (OTC PINK: EPOR) and Ronald Tucker, its CEO, announced, "EPIC's Board of Directors has authorized an offer to exchange shares of its Series A 5% Convertible Preferred Stock for common stock. The Board has voted to withdraw the announced stock dividend to its common shareholders; however, the seventh quarterly stock dividend to preferred shareholders will be paid as scheduled."

EPIC Establishes a Quarterly Divided Policy for Common Shareholders, and Declares Its First Quarterly Common Stock Dividend and Its Seventh Consecutive Quarterly Preferred Stock Dividend
Marketwired - Tue Dec 09, 8:04AM CST
EPIC Corporation Inc. (OTC PINK: EPOR) and Ronald Tucker, its CEO, announced, "EPIC's Board of Directors has established a policy for a quarterly divided to be paid in stock or cash to its common stock shareholders as of the quarters ending December 31, March 31, June 30 and September 30. The Board of Directors has declared it first quarterly dividend to common shareholders of record on December 24, 2014 and payable on December 31, 2014. The Board of Directors also declare the seventh consecutive quarterly stock dividend on its Series A 5% Convertible Preferred Stock to preferred shareholders of record on December 24, 2014, which will be paid December 31, 2014."

EPIC Creates New Revenue Source Introducing AcuFAB(R) Acupressure Insoles at Prices Anyone Can Afford
Marketwired - Mon Nov 24, 5:01AM CST
EPIC Corporation Inc. (PINKSHEETS: EPOR) and Ronald Tucker it CEO introduced "EPIC's AcuFAB ® Acupressure Insoles are made with a design patented medical textile AcuFAB ®. The design and architecture of the AcuFAB ® acupressure fabric is a unique spacer fabric and as a spacer fabric it provides technological solutions to medical conditions. AcuFAB ® Acupressure Insoles are comfortable like all insoles, but, due to being made with a medical textile, they have benefits not provided in the most expensive insoles made by others and AcuFAB ® acupressure insoles are sold at a price anyone can afford. The AcuFAB ® Acupressure Insoles are targeted to those who suffer from foot disorders and others suffering from excess foot fatigue by working on their feet all day."

EPIC Receives $1M License Fee From Healthcare Products Company
Marketwired - Wed Nov 19, 4:28PM CST
EPIC Corporation Inc. (PINKSHEETS: EPOR) announces the company has received a one time license fee of $1 Million from EPIC's Medicor Corporation for Marketing & Distribution rights of EPIC Fabric Healthcare Products in North America for medical market segments.

EPIC Acquires Exclusive Worldwide License to Healthcare Products Valued at $1.95M
Marketwired - Tue Nov 18, 11:20PM CST
EPIC Corporation Inc. (PINKSHEETS: EPOR) announces EPIC has acquired an exclusive worldwide license to all the rights to the EPIC Fabric Healthcare Products in exchange for all its ownership rights to the AcuFAB® trade name and design patent which was valued at $1.95 Million and receives a $1 Million License Fee from EPIC Medicor Corporation for Marketing & Distribution rights of EPIC Fabric Healthcare Products.

EPIC in Negotiations for Supply of Footwear Insoles Using Company's Patented Fabric Technology to Major Sport Shoe Manufacturers in $25 Billion Industry
Marketwired - Wed Nov 12, 5:01AM CST
EPIC Corporation (PINKSHEETS: EPOR) announces negotiations for supply of footwear insoles with major sport shoe manufacturers using the patented Epic Fabric Technology.

EPIC Proclaims Its Stock Is Undervalued and It Is Not a 'Shell Company'
Marketwired - Wed Oct 29, 8:08AM CDT
EPIC Corporation (PINKSHEETS: EPOR) ("EPIC" and Ronald S. Tucker, EPIC's president, declared "EPIC's common stock is undervalued and EPIC is not a 'shell company' as defined by Rule 144(i). Management believes that due to EPIC being a private company with a trading security, it is perceived as a 'shell company'."

EPIC States Conviction That It Has Substantial Intrinsic Value and EPIC's Common Stock Is Significantly Undervalued
Marketwired - Mon Oct 27, 1:22PM CDT
EPIC Corporation (PINKSHEETS: EPOR) ("EPIC" and Ronald S. Tucker, EPIC's president, declared "EPIC's management is convinced EPIC has a substantial intrinsic value and its common stock is significantly undervalued."

EPIC'S RX Healthcare is Licensed to Market and Distribute AcuFAB Products and EPIC is to Reinstitute Its Core Business
ACCESSWIRE - Thu Sep 11, 12:36PM CDT
Image: https://www.baystreet.ca/uploads/EPIC.png

EPIC Declares Quarterly Stock Dividend for Preferred Stockholders
ACCESSWIRE - Tue Sep 09, 8:20AM CDT
Image: https://www.baystreet.ca/uploads/ziyyoEPOR.png

Epic Enters a Marketing and Sales Joint Venture, and Files a 15C2-11 to Trade Its Preferred Stock
ACCESSWIRE - Tue Sep 02, 11:09AM CDT
Image: https://www.baystreet.ca/uploads/Epic%20Corporation.png

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 24

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 6

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 7

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 15

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 2

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Canada and Ukraine Fortify Defense with UGV Partnership

Updated Category News Views 7

New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 11

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 2

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Montesodi 2023: A Fresh Chapter in Chianti Excellence

Updated Category News Views 7

A Glass Filled with History and Nature's Whimsy When you pour a glass of Montesodi 2023, you’re not just tasting wine but a story—a saga that blends Tuscany’s rich vineyard history with last year's unpredictable weather. Marchesi Frescobaldi, a name that’s seen it all over its thousand years, has once again shown us how resilience and tradition can marry with...

Continue Reading
Quark Baby's Milk Warmer Debut at Vancouver & Dubai

Updated Category News Views 15

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Continue Reading

Top 5 Most Recently Viewed Articles

Seadrill and Petrobras Unite for Major $498 Million Deal

Updated Category News Views 246

Seadrill Secures Major Contract with Petrobras HAMILTON, Bermuda - Seadrill Limited (NYSE: SDRL), an offshore drilling contractor with a market capitalization of $2.46 billion and a trading price of $37.31, has successfully won a crucial contract with Brazilian oil giant Petrobras for its ultra-deepwater drillship, West Tellus. This significant agreement emerged from a...

Continue Reading
Investigation Launched into Acadia Healthcare Company’s Practices

Updated Category News Views 143

Acadia Healthcare Company Under Investigation Law Offices of Howard G. Smith has announced that it is conducting an investigation on behalf of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and its investors. This examination is prompted by potential violations of federal securities laws following serious allegations concerning the company’s operational practices....

Continue Reading
Cousins Maine Lobster Dishes New Lobster Roll Flight

Updated Category News Views 7

A Bite-Sized Maine Experience Get a whiff of this: Cousins Maine Lobster is rollin' out something that'll make your taste buds do a jig. They call it the Lobster Roll Flight, and it's about to shake things up for seafood lovers everywhere. Dropping on July 1st nationwide, this offering lets foodies sample three of Cousins' star rolls—Maine, Connecticut, and Garlic...

Continue Reading
Innovative Knee Support Product Designed for Pain Relief

Updated Category News Views 250

Introducing an Innovative Knee Support Solution In today's world, many individuals suffer from knee pain, often due to issues such as arthritis or weakened quadricep muscles. Recognizing this challenge, a doctor of physical therapy and an inventive team have come together to create a groundbreaking solution called the KNEE SUPPORT. This innovative product stands out as a...

Continue Reading
Recent Forecast Changes for TELA Bio Following Third Quarter Results

Updated Category News Views 185

Recent Forecast Changes for TELA Bio TELA Bio Inc (NASDAQ: TELA) has recently reported its third-quarter earnings, which presented a mix of results. The company incurred a loss of 19 cents per share, slightly better than analysts had anticipated at 20 cents. However, TELA Bio's quarterly sales totaled $20.7 million, falling short of estimates that predicted $21.8 million....

Continue Reading